Company intelligence / Profile preview
Probisearch
Madrid, Madrid, Spainprobisearch.com ↗
- Ownership
- Private
- Employees
- ~9
- Development stage
- Commercial
01
Overview
Probisearch has developed proprietary probiotic strains, including Ligilactobacillus salivarius PS11610, which have shown positive effects on modulating the microbiome in both human infertility cases and pediatric neurodevelopmental disorders. Clinical studies indicate improved outcomes in targeted populations, such as increased pregnancy success rates for couples undergoing assisted reproduction when treated with their probiotic strain.
- Therapeutic areas
- Infectious DiseasesNeurologyWomen's Health
- Modalities
- Live biotherapeutic product therapyMicrobial therapyProbiotic
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Probisearch.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Probisearch.